Regulation of endothelin-converting enzyme-1 (ECE-1) by the calcimimetic R-568

Pharmacological Research

Volumn 76, Issue , 2013, Pages 106-118

  Martínez Miguel, Patricia ^a   Medrano Andrés, Diana ^a   Lopes Martín, Vanessa ^a   Arribas Gómez, Ignacio ^a   Rodríguez Puyol, Manuel ^b,c   Rodríguez Puyol, Diego ^a,c   López Ongil, Susana ^a,c  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c Queen Sofía Institute for Research in Nephrology   (Spain)

Author keywords

Blood pressure; Calcimimetic; Endothelin 1; Endothelin converting enzyme 1; Nitric oxide

Indexed keywords

CALCIMIMETIC AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME; MESSENGER RNA; PHOSPHORAMIDON; TECALCET; ZINC;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; SINGLE DRUG DOSE; SYSTOLIC BLOOD PRESSURE; UPREGULATION; WESTERN BLOTTING;

BLOOD PRESSURE; CALCIMIMETIC; CALCIMIMETIC R-568; CALCIUM SENSING RECEPTOR; CAR; DMEM; DULBECCO'S MODIFIED EAGLE MEDIA; EA; EA.HY926 IS A HUMAN ENDOTHELIAL CELL LINE; ECE-1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN-1; ENDOTHELIN-CONVERTING ENZYME-1; ENOS; ET-1; NITRIC OXIDE; NO; PARATHYROID HORMONE; PTH; R-568; SBP; SYSTOLIC BLOOD PRESSURE; TTBS; TWEEN TRIS BUFFERED SALINE;

ANILINE COMPOUNDS; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; BLOOD PRESSURE; CALCIUM; CELL LINE; ENDOTHELIAL CELLS; ENDOTHELIN-1; HUMANS; MALE; METALLOENDOPEPTIDASES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, WISTAR;

EID: 84883145327     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2013.07.006     Document Type: Article

References (54)

1. J. Silver, R. Kilav, and T. Naveh-Many Mechanisms of secondary hyperparathyroidism Am J Physiol Renal Physiol 283 2002 F367 F376
2. D. Brancaccio, J. Bommer, and D. Coyne Vitamin D receptor activator selectively in the treatment of secondary hyperparathyroidism: understanding the differences among therapies Drugs 67 2007 1981 1998
3. J. Cunningham, M. Danase, K. Olson, P. Klassen, and G.M. Chertow Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism Kidney Int 68 2005 1793 1800
4. G.A. Block, G. ZaunD. Smits, M. Parsky, S. Brillhart, and K. Nieman Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients Kidney Int 78 2010 578 589
5. H. Ogata, E. Ritz, G. Odoni, K. Amann, and S.R. Orth Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors J Am Soc Nephrol 14 2003 959 967
6. O. Ivanovski, I.G. Nikolov, N. Joki, A. Caudrillier, O. Phan, and R. Mentaverri The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice Atherosclerosis 205 2009 55 62
7. C. Henley, M. Colloton, R.C. Cattley, E. Shatzen, D.A. Towler, and D. Lacey 1,25-dihidroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism Nephrol Dial Transplant 20 2005 1370 1377
8. T. Kawata, N. Nagano, M. Obi, S. Miyata, C. Koyama, and N. Kobayshi Cinacalcet suppressed calcification of the aorta and heart in uremic rats Kidney Int 74 2008 1270 1277
9. N. Koleganova, G. Piecha, E. Ritz, C.P. Schmitt, and M.L. Gross A calcimimetic (R-568), but not calcitriol, prevents vascular remodelling in uremia Kidney Int 75 2009 60 71
10. T. Odenwald, K. Nakagawa, C. Hadtstein, F. Roesch, P. Gohlke, and E. Ritz Acute blood pressure effects and chronic hypotensive action of calcimimetics in uremic rats J Am Soc Nephrol 17 2006 655 662
11. A. Rybczynska, K. Boblewski, A. Lehmann, C. Orlewska, H. Foks, and K. Drewnowska Calcimimetic R-568 induces hypotensive effect in SHR Am J Hypertens 18 2005 364 371
12. A. Rybczynska, K. Boblewski, A. Lehmann, C. Orlewska, and H. Foks Pharmacological activity of calcimimetic NPS-R-568 administered intravenously in rats: dose dependency Pharmacol Rep 58 2006 533 539
13. R.M. Fryer, J.A. Segreti, D.L. Widomski, P.H. Franklin, P.N. Banfor, and K.A. Koch Systemic activation of the calcium-sensing receptor produces acute effects on vascular tone and circulatory function in uremic and normal rats: focus on central versus peripheral control of vascular tone and blood pressure by cinacalcet J Pharmacol Exp Ther 323 2007 217 226
14. S. Smajilovic, S. Yano, R. Jabbari, and J. Tfelt-Hasen The calcium-sensing receptor and calcimimetics in blood pressure modulation Br J Pharmacol 164 2011 884 893
15. F.R. Carrasco, I. Pérez-Flores, N. Calvo, N. Ridao, A. Sanchez, and A. Barrientos Treatment of persistent hyperparathyroidism in renal transplant patients with cinacalcet improves control of blood pressure Transplant Proc 41 2009 2385 2387
16. E. Zitt, E. Woess, G. Mayer, and K. Lhotta Effect of cinacalcet on renal electrolyte handling and systemic arterial blood pressure in kidney transplant patients with persistent hyperparathytoidism Transplantation 92 2011 883 889
17. K.D. Schluter, and H.M. Piper Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide Cardiovasc Res 37 1998 34 41
18. K. Nakagawa, N. Parekh Koleganova, E. Ritz, F. Schaefer, and C.P. Schmitt Acute cardiovascular effects of the calcimimetic R-568 and its enantiomer S-568 in rats Pediatr Nephrol 24 2009 1385 1389
19. G-monomethyl-l-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal J Hypertens 10 1992 1025 1031
20. A. Calver, J. Collier, and P. Vallance Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes J Clin Invest 90 1992 2548 2554
21. P.L. Ludmer, A.P. Selwyn, T.L. Shook, R.R. Wayne, G.H. Mudge, and R.W. Alexander Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries N Engl J Med 315 1986 1046 1051
22. S.D. Katz, L. Biasucci, C. Sabba, J.A. Strom, G. Jondeau, and M. Galvao Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure J Am Coll Cardiol 19 1992 918 925
23. M. Yanagisawa, S. Kurihara, Y. Tomobe, M. Kobayashi, Y. Mitsui, and Y. Yazaki A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 1988 411 415
24. D. Xu, N. Emoto, A. Giaid, C. Slaughter, S. Kaw, and D. de Wit ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1 Cell 78 1994 473 485
25. A.J. Turner, and K. Tanzawa Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX FASEB J 11 1997 355 364
26. L. Muller, A. Barret, E. Etienne, R. Meidan, O. Valdenaire, and P. Corvol Heterodimerization of endothelin-converting enzyme-1 isoforms regulates the subcellular distribution of this metalloprotease J Biol Chem 278 2003 545 555
27. R.F. Furchgott, and J.V. Zawadzki The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 1980 373 376
28. R.M. Palmer, A.G. Ferrige, and S. Moncada Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 1987 524 526
29. G.P. Rossi, T.M. Seccia, and G.G. Nussdorfer Reciprocal regulation of endothelin-1 and nitric oxide: relevance in the physiology and pathology of the cardiovascular system Int Rev Cytol 209 2001 241 272
30. F. Ruschitzka, U. Moehrlen, T. Quaschning, M. Lachat, G. Noll, and S. Shaw Tissue endothelin-converting enzyme activity correlates with cardiovascular risk factors in coronary artery disease Circulation 102 2000 1086 1092
31. S. López-Ongil, M. Saura, C. Zaragoza, L. Gónzalez- Santiago, M. Rodríguez-Puyol, and C.J. Lowestein Hydrogen peroxide regulation of bovine endothelin-converting enzyme-1 Free Radic Biol Med 32 2002 406 413
32. S. López-Ongil, V. Senchak, M. Saura, C. Zaragoza, M. Ames, and B. Ballermann Superoxide regulation of endothelin-converting enzyme J Biol Chem 275 2000 26423 26427
33. P. Martínez-Miguel, V. Raoch, C. Zaragoza, J.M. Valdivielso, M. Rodríguez-Puyol, and D. Rodríguez-Puyol Endothelin converting enzyme-1 increases in atherosclerotic mice: potential role of oxidized low density lipoproteins J Lipid Res 50 2009 364 375
34. S. López-Ongil, M.L. Díez-Marqués, M. Griera, M. Rodríguez-Puyol, and D. Rodríguez-Puyol Crosstalk between mesangial and endothelial cells: angiotensin II down-regulates endothelin-converting enzyme 1 Cell Physiol Biochem 15 2005 135 144
35. V. Raoch, F. Rodríguez-Pascual, V. López-Martínez, D. Medrano-Andrés, M. Rodríguez-Puyol, and S. Lamas Nitric oxide decreases the expression of endothelin-converting enzyme-1 through mRNA destabilization Arterioscler Thromb Vasc Biol 31 2011 2577 2585
36. V. Raoch, P. Martínez-Miguel, I. Arribas-Gómez, M. Rodríguez-Puyol, D. Rodríguez-Puyol, and S. López-Ongil The peptide inhibitor CGS-26303 increases endothelin converting enzyme-1 expression in endothelial cells through accumulation of big endothelin-1 Br J Pharmacol 152 2007 313 322
37. A.H. Weston, M. Absi, D.T. Ward, J. Ohanian, R.H. Dodd, and P. Dauban Evidence in favour of a calcium-sensing receptor in arterial endothelial cells: studies with calindol and Calhex 231 Circ Res 97 2005 391 398
38. R.C. Ziegelstein, Y. Xiong, C. He, and Q. Hu Expression of a functional extracellular calcium-sensing receptor in human aortic endothelial cells Biochem Biophys Res Commun 342 2006 153 163
39. M. Nechama, I.Z. Ben-Dov, J. Silver, and T. Naveh-Many Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD Am J Physiol Renal Physiol 296 2009 F795 F800
40. D. Uhlmann, H. Witzigmann, H. Senninger, J. Hauss, and H.U. Spiegel Protective role of an endothelin-converting enzyme inhibitor (FR901533) in hepatic ischemia/reperfusion injury Microvasc Res 62 2001 43 54
41. M. Saura, C. Zaragoza, B. Herranz, M. Griera, L. Díez- Marqués, and D. Rodríguez-Puyol Nitric oxide regulates transforming growth factor-beta signalling in endothelial cells Circ Res 97 2005 1115 1123
42. T.P. Misko, R.J. Schilling, D. Salvemini, W.M. Moore, and M.G. Currie A fluorimetric assay for the measurement of nitrite in biological samples Anal Biochem 214 1993 11 16
43. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 1987 156 159
44. L. González-Santiago, S. López-Ongil, S. Lamas, C. Quereda, M. Rodríguez-Puyol, and D. Rodríguez-Puyol Imbalance in endothelial vasoactive factors as a possible cause of cyclosporin toxicity: a role for endothelin-converting enzyme J Lab Clin Med 136 2000 395 401
45. O. Valdenaire, E. Rohrbacher, and M.G. Mattei Organization of the gene encoding the human endothelin-converting enzyme-1 (ECE-1) J Biol Chem 270 1995 29794 29798
46. G. Pérez-Rivero, M.P. Ruíz-Torres, J.V. Rivas-Elena, M. Jerkic, M.L. Díez-Marqués, and J.M. López-Novoa Mice deficient in telomerase activity develop hypertension because of an excess of endothelin production Circulation 114 2006 309 317
47. K. Shimada, M. Takahashi, A.J. Turner, and K. Tanzawa Rat endothelin-converting enzyme-1 forms a dimmer through Cys412 with a similar catalytic mechanism and a distinct substrate binding mechanism compared with neutral endopeptidase-24.11 Biochem J 315 1996 863 867
48. G.C. Kundu, and I.B. Wilson Identification of endothelin-converting enzyme in bovine lung membranes using a new fluorogenic substrate Life Sci 50 1992 965 970
49. G.C. Kundu, and I.B. Wilson Endothelin-converting enzyme: the binding of metal ions Int J Pept Protein Res 42 1993 64 67
50. T. Peltonen, P. Taskinen, J. Näpänkagas, H. Leskinen, P. Ohtonen, and Y. Soini Increase in tissue endothelin-1 and ETA receptor levels in human aortic valve stenosis Eur Heart J 30 2009 242 249
51. N. Makita, J. Sato, K. Manaka, Y. Shoji, A. Oishi, and M. Hashimoto An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations Proc Natl Acad Sci U S A 104 2007 5443 5448
52. J. Tfelt-Hansen, J.L. Hansen, S. Smajilovic, E.F. Terwilliger, S. Haunso, and S.P. Sheikh Calcium receptor is functionally expressed in rat neonatal ventricular cardiomyocytes Am J Physiol Heart Circ Physiol 290 2006 H1165 H1171
53. 2+ channels Br J Pharmacol 162 2011 749 762
54. D. Isaka, N. Emoto, S.B. Raharjo, M. Yokoyama, and M. Matsuo The effects of phosphoramidon on the expression of human endothelin-converting enzyme-1 (ECE-1) isoforms J Cardiovasc Pharmacol 42 2003 136 141